15-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1147 15 783 87 1059 167 1017
ERLYTX 74 2 104 5 61 8 49
GI 162 4 209 15 183 29 177
GU 403 13 678 53 645 95 578
LEUK 165 5 261 17 207 31 189
LUNG 206 3 157 13 158 24 146
LYMPH 428 7 365 34 414 71 432
MELAN 8 0 0 1 12 1 6
MMYEL 116 3 157 17 207 22 134
MULT 49 0 0 2 24 3 18
OTHER 44 1 52 2 24 3 18
Total 2802 53 2766 246 2994 454 2764

15-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 215 4 209 19 231 39 237
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 0 0
GU 5 0 0 1 12 3 18
LEUK 617 11 574 60 731 108 657
LUNG 367 3 157 42 511 64 390
LYMPH 1 0 0 1 12 1 6
OTHER 15 0 0 0 0 4 24
PEOLC 63 0 0 3 37 3 18
PREV 232 3 157 21 256 27 164
SXQOL 651 3 157 44 536 99 603
Total 2169 24 1254 191 2326 348 2117

15-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1147 15 783 87 1059 167 1017
CCD 215 4 209 19 231 39 237
ERLYTX 76 2 104 5 61 8 49
GI 163 4 209 15 183 29 177
GU 408 13 678 54 657 98 597
LEUK 782 16 835 77 937 139 846
LUNG 573 6 313 55 670 88 536
LYMPH 429 7 365 35 426 72 438
MELAN 8 0 0 1 12 1 6
MMYEL 116 3 157 17 207 22 134
MULT 49 0 0 2 24 3 18
OTHER 59 1 52 2 24 7 43
PEOLC 63 0 0 3 37 3 18
PREV 232 3 157 21 256 27 164
SXQOL 651 3 157 44 536 99 603
Total 4971 77 4019 437 5320 802 4883

15-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 705 13 678 55 670 96 584
ERLYTX 54 2 104 5 61 7 43
GI 126 4 209 11 134 24 146
GU 297 9 470 35 426 64 390
LEUK 102 4 209 10 122 15 91
LUNG 130 2 104 7 85 17 103
LYMPH 279 4 209 19 231 46 280
MELAN 8 0 0 1 12 1 6
MMYEL 65 2 104 12 146 13 79
MULT 20 0 0 2 24 2 12
OTHER 43 0 0 1 12 2 12
Total 1829 40 2087 158 1923 287 1746

15-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 158 3 157 12 146 28 170
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 0 0
GU 5 0 0 1 12 3 18
LEUK 249 3 157 22 268 35 213
LUNG 225 2 104 28 341 43 262
LYMPH 1 0 0 1 12 1 6
OTHER 15 0 0 0 0 4 24
PEOLC 53 0 0 3 37 3 18
PREV 231 2 104 20 244 26 158
SXQOL 474 3 157 33 402 73 444
Total 1414 13 679 120 1462 216 1313

15-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 901 15 783 74 901 141 858
CCD 172 3 157 10 122 23 140
ERLYTX 56 2 104 5 61 7 43
GI 142 5 261 14 170 31 189
GU 334 9 470 37 450 71 432
LEUK 354 7 365 32 390 50 304
LUNG 385 4 209 37 450 67 408
LYMPH 280 4 209 20 244 47 286
MELAN 8 0 0 1 12 1 6
MMYEL 65 2 104 12 146 13 79
MULT 42 0 0 4 49 9 55
OTHER 123 0 0 1 12 6 37
PEOLC 53 0 0 3 37 3 18
PREV 231 2 104 20 244 26 158
SXQOL 474 3 157 33 402 73 444
Total 3620 56 2923 303 3690 568 3457

15-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 991 15 783 83 1011 158 962
ERLYTX 70 2 104 5 61 8 49
GI 96 1 52 10 122 18 110
GU 292 11 574 43 524 71 432
LEUK 136 5 261 16 195 28 170
LUNG 180 1 52 11 134 21 128
LYMPH 355 7 365 33 402 63 384
MMYEL 103 3 157 16 195 21 128
MULT 49 0 0 2 24 3 18
Total 2272 45 2348 219 2668 391 2381

15-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1899 31 1618 161 1960 292 1778
AFFIL 125 1 52 4 49 8 49
CCOP/NCORP 1219 21 1096 113 1376 203 1236
Non-SWOG 1725 21 1096 156 1899 296 1802
Total 4968 74 3862 434 5284 799 4865

15-OCT-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S2507 ALL/ALAL, KMT2A-trans, Blina +/- Revumenib 1 Y 22-SEP-26

15-OCT-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
OTHER NRGGY026 Endomet, Stage I-IV, Pac/Car w/ HER HYL/PHE 1 E 29-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 1 E 28-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 2 E 28-SEP-26
SXQOL NRG-CC013 HN Squamous Cell, Rec Chemo, BMX 1 E 23-SEP-26
OTHER NRGHN009 HN, RT + HD Cisp vs RT + LD Cisp for SCCHN 1 E 02-OCT-26

15-OCT-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 11
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 11
LUNG LUNGMAP NSCLC, Adv, Master 2 8
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 7
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 6
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 3 4
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 4
LUNG LUNGMAP NSCLC, Adv, Master 1 3
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 3
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 3
GU S2427 Blad, MIBC, RT + Pembrolizumab 1 3